You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 118 No. 4, April 1992 TABLE OF CONTENTS
  Archives
  •  Online Features
  ORIGINAL ARTICLES
 This Article
 •References
 •Full text PDF
 • Reply to article
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

Factors Influencing Survival in Ethmoid Sinus Cancer

Dennis H. Kraus, MD; Bruce M. Sterman, MD; Howard L. Levine, MD; Benjamin G. Wood, MD; Harvey M. Tucker, MD; Pierre Lavertu, MD

Arch Otolaryngol Head Neck Surg. 1992;118(4):367-372.


Abstract

• Nineteen patients with primary ethmoid sinus malignancies were treated at the Cleveland (Ohio) Clinic Foundation between 1976 and 1989. Pathologic diagnoses included adenocarcinoma (eight), sarcoma (four), squamous cell carcinoma (three), mucoepidermoid carcinoma (two), adenoid cystic carcinoma (one), and undifferentiated carcinoma (one). All patients underwent surgical resection: 13 had craniofacial resection, four had craniofacial resection/orbital exenteration, one had radical ethmoidectomy/maxillectomy/orbital exenteration, and one had transantral ethmoidectomy. Twelve patients had combined treatment with radiation therapy. Ten patients were alive with no evidence of disease. A trend toward improved prognosis is associated with negative surgical margins. Preservation of the globe was not associated with local recurrence at this site. A poor prognosis was noted with involvement of the dura, brain, nasopharynx, or sphenoid sinus.

(Arch Otolaryngol Head Neck Surg. 1992;118:367-372)



Author Affiliations

From the Department of Otolaryngology and Communicative Disorders, The Cleveland (Ohio) Clinic Foundation. Dr Kraus is now with the Memorial Sloan-Kettering Cancer Center, New York, NY.


Footnotes

Accepted for publication October 17, 1991.

Presented at the spring meeting of the American Society of Head and Neck Surgery, Palm Beach, Fla, May 1, 1990.

Reprint requests to the Department of Otolaryngology and Communicative Disorders, The Cleveland Clinic Foundation, 9500 Euclid Ave, Cleveland, OH 44195-5034 (Dr Lavertu).



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Intra-arterial Cisplatin and Concomitant Radiation Therapy Followed by Surgery for Advanced Paranasal Sinus Cancer
Samant et al.
Arch Otolaryngol Head Neck Surg 2004;130:948-955.
ABSTRACT | FULL TEXT  

Craniofacial Resection for Malignant Tumors Involving the Anterior Skull Base
Shah et al.
Arch Otolaryngol Head Neck Surg 1997;123:1312-1317.
ABSTRACT  

Cisplatin-Based Neoadjuvant Chemotherapy and Combined Resection for Ethmoid Sinus Adenocarcinoma Reaching and/or Invading the Skull Base
Brasnu et al.
Arch Otolaryngol Head Neck Surg 1996;122:765-768.
ABSTRACT  

RESIDENTS PAGE: PATHOLOGY
ASKIN and WESTRA
Arch Otolaryngol Head Neck Surg 1995;121:1320-1323.
ABSTRACT  

Craniofacial Resection: An Analysis of 73 Cases
Catalano et al.
Arch Otolaryngol Head Neck Surg 1994;120:1203-1208.
ABSTRACT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1992 American Medical Association. All Rights Reserved.